1.7. Analysis.

Comparison 1 RISPERIDONE vs PLACEBO, Outcome 7 Mental state: 2. skewed data ‐ short term (up to 12 weeks).

Mental state: 2. skewed data ‐ short term (up to 12 weeks)
Study	Intervention	Mean	SD	N
average endpoint score BPRS total (high=poor)
Pai 2002	Resperidone	14.7	7.4	22
Pai 2002	Placebo	19.0	12.2	20
average change score of CGI‐C (larger decline=good)
Potkin 2006	Resperidone	2.4	1.23	152
Potkin 2006	Placebo	2.9	0.84	71
average change score of CGI‐SI (larger decline=good)
Potkin 2006	Resperidone	‐1.84	1.23	152
Potkin 2006	Placebo	‐1.1	0.84	71
average change score of HAM‐D‐17 (larger decline=good)
Potkin 2006	Resperidone	‐5.6	4.93	152
Potkin 2006	Placebo	‐4.4	4.21	71
average change score of PANSS total (larger decline=good)
Potkin 2006	Resperidone	‐27.7	18.49	152
Potkin 2006	Placebo	‐20.2	16.85	71
average change score of PANSS negative symptom (larger decline=good)
Potkin 2006	Resperidone	‐4.0	4.93	152
Potkin 2006	Placebo	‐3.5	5.06	71
average change score of PANSS positive symptom (larger decline=good)
Potkin 2006	Resperidone	‐8.7	6.16	152
Potkin 2006	Placebo	‐5.3	5.9	71